Evidence map›Paper›PMID 21832090›Full record

ArticleThe Journal of biological chemistry2011

Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.

Madhuchhanda Mandal, Jing Wei, Ping Zhong, Jia Cheng, Lara J Duffney, Wenhua Liu, Eunice Y Yuen, Alison E Twelvetrees, Shihua Li, Xiao-Jiang Li and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Molecular Mechanisms of AMPA Receptor Trafficking in the Nervous System.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Article
  11. Article
  12. Review
  13. Huntingtin and the Synapse.Frontiers in cellular neuroscience · 2021
    Review
  14. Article
  15. Article
  16. Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.Cold Spring Harbor perspectives in medicine · 2017
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Madhuchhanda MandalDepartment of Physiology and Biophysics, State University of New York, at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York 14214, USA.
Jing Wei
Ping Zhong
Jia Cheng
Lara J Duffney
Wenhua Liu
Eunice Y Yuen
Alison E Twelvetrees
Shihua Li
Xiao-Jiang Li
Josef T Kittler
Zhen Yan
University at Buffalo, State University of New York · USEmory University · USUniversity College London · GB

Funding

Synaptic toxicity of Huntington disease proteinR01AG019206 · NIA · EMORY UNIVERSITY · PI LI, XIAO-JIANG · 2001 to 2016
$4.5M
Research Training for Medical Students & Physician-Scientists in Child PsychiatryR25MH077823 · NIMH · YALE UNIVERSITY · PI ANDRES S MARTIN · 2006 to 2026
$4.0M
Aberrant GABAAR Trafficking and Synaptic Inhibition in Huntington's DiseaseR21NS069929 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI YAN, ZHEN · 2010 to 2011
$431k
Medical Research Council G0802377NIA NIH HHS R01 AG019206NIMH NIH HHS R25 MH077823NINDS NIH HHS NS69929NINDS NIH HHS R21 NS069929
6 · The paper itself

Abstract

Emerging evidence from studies of Huntington disease (HD) pathophysiology suggests that huntingtin (htt) and its associated protein HAP1 participate in intracellular trafficking and synaptic function. However, it is largely unknown whether AMPA receptor trafficking, which is crucial for controlling the efficacy of synaptic excitation, is affected by the mutant huntingtin with polyglutamine expansion (polyQ-htt). In this study, we found that expressing polyQ-htt in neuronal cultures significantly decreased the amplitude and frequency of AMPAR-mediated miniature excitatory postsynaptic current (mEPSC), while expressing wild-type huntingtin (WT-htt) increased mEPSC. AMPAR-mediated synaptic transmission was also impaired in a transgenic mouse model of HD expressing polyQ-htt. The effect of polyQ-htt on mEPSC was mimicked by knockdown of HAP1 and occluded by the dominant negative HAP1. Moreover, we found that huntingtin affected mESPC via a mechanism depending on the kinesin motor protein, KIF5, which controls the transport of GluR2-containing AMPARs along microtubules in dendrites. The GluR2/KIF5/HAP1 complex was disrupted and dissociated from microtubules in the HD mouse model. Together, these data suggest that AMPAR trafficking and function is impaired by mutant huntingtin, presumably due to the interference of KIF5-mediated microtubule-based transport of AMPA receptors. The diminished strength of glutamatergic transmission could contribute to the deficits in movement control and cognitive processes in HD conditions.

Indexed as

MutationSynaptic PotentialsSynaptic TransmissionAnimalsHEK293 CellsHumansHuntingtin ProteinMiceMice, TransgenicNerve Tissue ProteinsNeuronsNuclear ProteinsPeptidesProtein TransportRatsReceptors, AMPAglutamate receptor ionotropic, AMPA 2Hap1 protein, mouseHap1 protein, ratHtt protein, mouseHtt protein, ratHuntingtin ProteinNerve Tissue ProteinsNuclear ProteinsPeptidespolyglutamineReceptors, AMPA

Identifiers

PMID21832090
PMCPMC3190808
OpenAlexW1509721882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.